-transparent.png){kind=logo}
Leukocyte locomotion (LL) of 40 patients with rheumatoid arthritis (RA) was found to be unimpaired as compared to LL of 23 control individuals (p Greater Than 0.2). Casein and zymosan activated human sera were used as cytotaxins, and the sera of RA patients proved to be activatable in the same way as control sera in that they produced a similar chemotactic activity (p Greater Than 0.2). However, RA sera inhibited LL significantly (p Less Than 0.01) in comparison to control sera. This phenomenon was unchanged after elimination of immune complexes be ultracentrifugation, but could be reversed, after incubation of cells with RA sera, by reincubation with control sera.
Related Publications
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
June 1989,
Acta orthopaedica Scandinavica,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
February 2006,
Pathophysiology : the official journal of the International Society for Pathophysiology,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
January 1976,
Arthritis and rheumatism,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
January 1984,
International archives of allergy and applied immunology,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
January 1990,
The Turkish journal of pediatrics,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
October 1978,
La Nouvelle presse medicale,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
August 2017,
Rheumatic diseases clinics of North America,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
December 1972,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
January 1979,
The Journal of rheumatology,
G Lanzer, and
C Zielinski, and
W Knapp, and
R Eberl, and
C Steffen
January 1980,
Reviews of infectious diseases,
